Waystar Holding Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw 22% revenue growth, strong AI-driven bookings, and margin expansion, with provider solutions outpacing patient payments. Guidance for 2026 is reaffirmed, and integration of Iodine and new AI SKUs are driving momentum and expanding the addressable market.
-
Waystar is leveraging its cloud-native, AI-powered platform and proprietary data to lead healthcare revenue cycle transformation, achieving strong financial performance and expanding its addressable market. Integration of Iodine and agentic AI capabilities further enhance automation and client value.
Fiscal Year 2025
-
Delivered record Q4 and FY2025 results, surpassing $1B in revenue and exceeding guidance. Strong AI-driven growth, robust client retention, and successful Iodine integration position the company for 17% revenue growth and 16% adjusted EBITDA growth in 2026.
-
A cloud-native healthcare platform leverages AI to automate revenue cycle management, achieving strong revenue growth, high EBITDA margins, and robust free cash flow. Recent AI-driven product launches and the Iodine acquisition are fueling cross-sell opportunities and operational efficiency.
-
The discussion highlighted strong demand for end-to-end, AI-driven revenue cycle solutions, with recent acquisitions and generative AI products driving measurable efficiency gains. The company maintains a robust growth outlook, leveraging cross-sell opportunities and ongoing innovation.
-
Q3 saw 12% revenue growth to $269M and a 42% adjusted EBITDA margin, with strong client retention and expansion. The Iodine acquisition expands the market and accelerates innovation, prompting raised 2025 guidance and continued investment in AI-powered solutions.
-
AI-driven automation is transforming healthcare payments, reducing manual work, preventing denials, and accelerating reimbursements. Integrated solutions improve financial outcomes, patient experience, and operational efficiency, all while maintaining top-tier security and trust.
-
Waystar leverages a cloud-native, AI-driven platform to streamline healthcare payments, reduce administrative waste, and deliver strong ROI for providers. Recent growth is fueled by rapid deployments, high client retention, and the strategic acquisition of Iodine Software, which enhances AI capabilities and data integration.
-
Q2 2025 saw 15% revenue growth to $271M and a 42% adjusted EBITDA margin, driven by strong demand for AI-powered solutions and rapid onboarding of new clients. Full-year guidance was raised, and the Iodine Software acquisition is expected to expand the addressable market and accelerate innovation.
-
The acquisition of Iodine Software for $1.25 billion is a strategic move to expand AI-powered healthcare solutions, enhance cross-sell opportunities, and accelerate innovation. The deal is expected to be immediately accretive, deliver $15M+ in cost synergies, and close by year-end 2025.
-
Waystar highlighted strong double-digit revenue growth, robust EBITDA margins, and a cloud-native platform that leverages AI to streamline healthcare payments. The company’s high client retention, broad integration, and ongoing innovation position it for continued expansion in a $15B market.
-
Q1 2025 saw 14% revenue and 16% adjusted EBITDA growth, driven by strong client expansion, high net revenue retention, and rapid adoption of AI-powered solutions. Full-year guidance was raised for both revenue and EBITDA, with continued focus on innovation, operational efficiency, and disciplined capital allocation.
-
A leading healthcare payment software provider highlighted strong growth, high client retention, and rapid AI-driven innovation at its first public company conference. The launch of Altitude AI, a generative AI platform, aims to automate denial management and boost provider efficiency.
Fiscal Year 2024
-
Revenue grew 19% in 2024, driven by new client wins and rapid onboarding after a competitor's cyber attack. Adjusted EBITDA margin exceeded 40%, and 2025 guidance calls for 7% reported and 10% normalized revenue growth, with continued investment in AI and efficiency.
-
A leading healthcare payments software provider reported strong Q3 results, with 109.5% net revenue retention and durable revenue growth, aided by onboarding over 30,000 new providers after a competitor's cyber event. The business maintains 40% EBITDA margins, invests in AI and digital solutions, and sees continued market share gains and predictable growth.
-
Waystar highlighted strong growth in 2024, driven by increased demand for its cloud-based healthcare payment software, especially after a competitor's cyber attack. The company maintains high retention, robust margins, and a disciplined approach to capital allocation, while focusing on automation, cybersecurity, and expanding direct payer connections.
-
Q3 2024 saw 22% revenue growth to $240M, driven by strong client retention, rapid onboarding after a competitor's cyber event, and platform innovation. Adjusted EBITDA margin held at 40%, and 2024 guidance was raised, with continued focus on AI and automation.
-
Strong Q2 growth and a successful IPO highlight momentum, with a modern, AI-driven platform driving efficiency and market share. Cybersecurity events accelerated client migration, while integrated patient payment solutions and robust partnerships support continued expansion.
-
Q2 revenue grew 20% year-over-year to $235M, with strong client retention, new sales, and rapid onboarding of providers after a competitor's cyber attack. Adjusted EBITDA margin held at 40%, and FY 2024 revenue is guided to 15% growth at midpoint.